sGP Serves as a Structural Protein in Ebola Virus Infection

被引:17
|
作者
Iwasa, Ayaka
Shimojima, Masayuki [3 ]
Kawaoka, Yoshihiro [1 ,2 ,4 ,5 ]
机构
[1] Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Div Virol,Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1088639, Japan
[3] Yamaguchi Univ, Fac Agr, Lab Vet Microbiol, Saitama, Japan
[4] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan
[5] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA
来源
关键词
SMALL GLYCOPROTEIN SGP; VIRION GLYCOPROTEINS; DISTINCT MECHANISMS; ANTIBODY; BINDING; ENTRY; IDENTIFICATION; RESIDUES; RECEPTOR; CYTOTOXICITY;
D O I
10.1093/infdis/jir313
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Methods. We expressed ZEBOV GP(1,2), VP40, and NP proteins, together with sGP protein, from expression plasmids and examined the resultant virus-like particles by using Western blot. Cells expressing GP(2) in combination with either GP(1) or sGP were analyzed by using flow cytometry with the KZ52 antibody, which recognizes a GP(1,2) conformational epitope. A VSV pseudotype, VSV delta G*, which expresses a GFP reporter gene instead of the G protein, was used to produce pseudotyped viruses encoding sGP and variants of GP to test the contribution of sGP to infectivity. Results. Western blot and flow cytometric analyses suggested the existence of a covalently linked sGP-GP(2) molecule. VSV delta G*(sGP + GP(2)) and VSV delta G*(GP(1,2)) infected Vero E6 cells and were neutralized by the KZ52 antibody. Overexpression of sGP reduced the titer of VSV delta G*(GP(1,2)). Conclusions. ZEBOV sGP can substitute for GP(1), forming a sGP-GP(2) complex and conferring infectivity. Our studies suggest a novel role for sGP as a structural protein.
引用
收藏
页码:S897 / S903
页数:7
相关论文
共 50 条
  • [1] Disulfide bond assignment of the Ebola virus secreted glycoprotein SGP
    Barrientos, LG
    Martin, AM
    Rollin, PE
    Sanchez, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 323 (02) : 696 - 702
  • [2] Structures of Ebola virus GP and sGP in complex with therapeutic antibodies
    Pallesen J.
    Murin C.D.
    De Val N.
    Cottrell C.A.
    Hastie K.M.
    Turner H.L.
    Fusco M.L.
    Flyak A.I.
    Zeitlin L.
    Crowe J.E.
    Andersen K.G.
    Saphire E.O.
    Ward A.B.
    Nature Microbiology, 1 (9)
  • [3] Structures of Ebola virus GP and sGP in complex with therapeutic antibodies
    Pallesen, Jesper
    Murin, Charles D.
    de Val, Natalia
    Cottrell, Christopher A.
    Hastie, Kathryn M.
    Turner, Hannah L.
    Fusco, Marnie L.
    Flyak, Andrew I.
    Zeitlin, Larry
    Crowe, James E., Jr.
    Andersen, Kristian G.
    Saphire, Erica Ollmann
    Ward, Andrew B.
    NATURE MICROBIOLOGY, 2016, 1 (09):
  • [4] Infection by the Ebola virus
    Roca, B
    Simon, E
    MEDICINA CLINICA, 1996, 107 (07): : 255 - 256
  • [5] Ebola Virus Infection
    Bozkurt, Ilkay
    Leblebicioglu, Hakan
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2014, 3
  • [6] Host protein mimics viral protein to hinder infection by Ebola virus
    Seiya Yamayoshi
    Yoshihiro Kawaoka
    Nature, 2019, 566 (7743) : 190 - 191
  • [7] Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus
    Falzarano, Darryl
    Krokhin, Oleg
    Wahl-Jensen, Victoria
    Seebach, Jochen
    Wolf, Kristin
    Schnittler, Hans-Joachim
    Feldmann, Heinz
    CHEMBIOCHEM, 2006, 7 (10) : 1605 - 1611
  • [8] Evidence against Ebola virus sGP binding to human neutrophils by a specific receptor
    Sui, JH
    Marasco, WA
    VIROLOGY, 2002, 303 (01) : 9 - 14
  • [9] Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice
    Lennemann, Nicholas J.
    Herbert, Andrew S.
    Brouillette, Rachel
    Rhein, Bethany
    Bakken, Russell A.
    Perschbacher, Katherine J.
    Cooney, Ashley L.
    Miller-Hunt, Catherine L.
    Ten Eyck, Patrick
    Biggins, Julia
    Olinger, Gene
    Dye, John M.
    Maury, Wendy
    JOURNAL OF VIROLOGY, 2017, 91 (17)
  • [10] Surviving Ebola virus infection
    Gary J. Nabel
    Nature Medicine, 1999, 5 : 373 - 374